Skip to content

Norwegian Stoma Trial

Norwegian Stoma Trial - Open-label, Multicenter Trial

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05243771
Enrollment
400
Registered
2022-02-17
Start date
2022-09-01
Completion date
2025-08-31
Last updated
2023-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Complication,Postoperative, Ileostomy; Complications, Quality of Life, Rectal Cancer

Brief summary

The Norwegian Stoma Trial is an open-label multicenter trial investigating the use of stomas, both diveriting and permanent, in the surgical treatment of rectal cancer. The objective is to compare the chosen strategy to surgical complications, health realted quality of life and length of stay.

Detailed description

In this national, multicenter study the study group will investigate whether patients with rectal adenocarcinoma undergoing a resection with an anastomosis will benefit from a diverting stoma or not, by studying how choice of surgery affects complications. In addition the study group will investigate complication rates and HRQoL among patients receiving a permanent colostomy and compare this to patients who have received an anastomosis. The investigators know that there are different approaches to the use of stomas (both permanent and diverting) between different hospitals. The investigators aim to discover potential differences in complication rates, length of stay and HRQoL among these patients and compare this to the chosen strategy. Health related quality of life will be measured using the EORTC CR 29 and EORTC CR 30 questionnares. Bowel function will also be monitored using the LARS (low anterior resection syndrome) score.

Interventions

PROCEDURERectal resection with diverting stoma

Patients in this group will receive a rectal resection with an anastomosis and also a diverting stoma will be created

PROCEDURERectal resection without diverting stoma

Patients in this group will receive a rectal resection with an anastomosis and no diverting stoma will be created

PROCEDURERectal resection with permanent colostomy

Patients in this group will receive a rectal resection and a permanent colostomy will be created

Sponsors

Haukeland University Hospital
CollaboratorOTHER
University Hospital of North Norway
CollaboratorOTHER
Helse Nord-Trøndelag HF
CollaboratorOTHER
St. Olavs Hospital
CollaboratorOTHER
Alesund Hospital
CollaboratorOTHER
Helse Fonna
CollaboratorOTHER
Helse Stavanger HF
CollaboratorOTHER_GOV
Sorlandet Hospital HF
CollaboratorOTHER_GOV
Sykehuset Telemark
CollaboratorOTHER_GOV
Vestre Viken Hospital Trust
CollaboratorOTHER
Asker & Baerum Hospital
CollaboratorOTHER
Ullevaal University Hospital
CollaboratorOTHER
Oslo University Hospital
CollaboratorOTHER
Ostfold Hospital Trust
CollaboratorOTHER
University Hospital, Akershus
CollaboratorOTHER
Hamar Hospital
CollaboratorUNKNOWN
Gjøvik Hospital
CollaboratorUNKNOWN
Bodø Hospital
CollaboratorUNKNOWN
The Hospital of Vestfold
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* Age 18 years or older * Verified rectal adenocarcinoma by biopsy * Tumor located in the rectum with lower border of the tumor located 15 cm or less from the anal verge. * Given informed consent

Exclusion criteria

* Advanced tumor stage requiring exenterative surgery beyond a convetional APR or TME. * Stage IV disease * Synchronous colon cancer necessitating a total colectomy * Other concomitant disease(s) which will complicate participation. * Unwillingness to give informed consent

Design outcomes

Primary

MeasureTime frameDescription
Surgical complications graded as Accordion grade 3 or moreMeasured one year after the primary surgeryThe study group will investigate whether patients undergoing rectal resection with an anastomosis with a diverting stoma will have higher complication rates compared to patients who do not recieve a diverting stoma.

Secondary

MeasureTime frameDescription
Generic health related quality of life measured by the European Organization for Research and Treatment of Cancer (EORTC) C30 questionnaireOne year after the primary surgeryGeneric health related quality of life is measured using the EORTC C30 questionnaire. Investigate whether patients receiving a rectal resection with a primary colostomy have poorer health related quality of life compared to patients receiving an anastomosis.
Bowel function measured by the Low Anterior Resection Syndrome (LARS) scoreOne year after the primary surgeryBowel function is measured using the Low Anterior Resection Syndrome score. The score ranges from 0 to 42 points The higher the score, the worse the bowel function. Investigate whether patients undergoing rectal resection with an anastomosis with a diverting stoma will have higher LARS scores compared to patients who do not recieve a diverting stoma.
Surgical complications graded as Accordion grade 3 or moreMeasured one year after the primary surgeryInvestigate whether patients receiving a rectal resection with a primary colostomy have lower complication rates compared to patients receiving an anastomosis
Total length of hospital stayMeasured one year after the primary surgeryNumber of days admitted at hospital. The study group will investigate whether patients undergoing rectal resection with an anastomosis with a diverting stoma will have a higher number of days admitted to hospital compared to patients who do not recieve a diverting stoma.
Disease specific health related quality of life measured by the European Organization for Research and Treatment of Cancer (EORTC) CR29 questionnnaireOne year after the primary surgeryDisease specific health related quality of life measured by the EORTC CR29 questionnnaire. Investigate whether patients undergoing rectal resection with an anastomosis with a diverting stoma will have poorer health related quality of life compared to patients who do not recieve a diverting stoma.
Disease specific health related quality of life measured by the European Organization for Research and Treatment of Cancer (EORTC) CR29 questionnnaire.One year after the primary surgeryDisease specific health related quality of life measured by the EORTC CR29 questionnnaire. Investigate whether patients receiving a rectal resection with a primary colostomy have poorer health related quality of life compared to patients receiving an anastomosis.
Generic health related quality of life measured by the European Organization for Research and Treatment of Cancer (EORTC) C30 questionnaire.One year after the primary surgeryGeneric health related quality of life is measured using the EORTC C30 questionnaire. Investigate whether patients undergoing rectal resection with an anastomosis with a diverting stoma will have poorer health related quality of life compared to patients who do not recieve a diverting stoma.

Countries

Norway

Contacts

Primary ContactLars Thomas Seeberg, MD, PhD
ltseeberg@gmail.com+4733342000
Backup ContactLars Grønvold, MD
lagr1@siv.no+4733342000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026